Matheus da Silva Ferreira
Research Subjects
Matheus da Silva Ferreira has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Marcos Manoel Honorato
Faculty of Medicine, University of the State of Pará (UEPA), Santarém, Brazil
6 shared publications - Samuel Oliveira de Amorim
Faculty of Medicine, University of the State of Pará (UEPA), Santarém, Brazil
6 shared publications - Felipe Henrique Lima Pereira
Faculty of Medicine, University of the State of Pará (UEPA), Santarém, Brazil
5 shared publications - José Alexandre Neto
Faculty of Medicine, University of the State of Pará (UEPA), Santarém, Brazil
5 shared publications - Nathan Fellipe Cardoso da Silva
Faculty of Medicine, University of the State of Pará (UEPA), Santarém, Brazil
3 shared publications - Cid Soares
Faculty of Medicine, UniAtenas, Passos, Brazil
2 shared publications
Latest Publications
- 25 August 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (9) , 735
Combined antithrombotic therapy vs. oral anticoagulation alone for ischemic stroke with concomitant atrial fibrillation and large artery atherosclerosis: a systematic review and meta-analysis
Background Treating ischemic stroke patients who have both nonvalvular atrial fibrillation (NVAF) and large artery atherosclerosis (LAA) presents a clinical challenge. It remains unclear whether adding antiplatelet therapy (APT) to oral anticoagulation (OAC) reduces stroke risk or only increases the danger of hemorrhage. Methods We conducted a systematic review and meta-analysis of randomized and observational studies to compare OAC monotherapy against combined therapy (OAC + APT) in patients with recent ischemic stroke, NVAF, and LAA. PubMed, Embase, Scopus, Cochrane Library, and Web of Science were searched from inception to December 2025. We applied random-effects models to estimate Risk Ratios (RR). Results Seven studies comprising 14,884 patients were included. Combined therapy was not associated with a significant reduction in recurrent ischemic stroke (RR 0.98; 95% CI: 0.92–1.04; p = 0.55) or all-cause mortality (RR 1.11; 95% CI: 0.98–1.26; p = 0.09) compared to OAC monotherapy. Conversely, the combined strategy was associated with a statistically significant increase in the risk of major bleeding (RR 1.49; 95% CI: 1.04–2.15; p = 0.03). Conclusion Our findings indicate that adding antiplatelets to anticoagulation in patients with stroke, AF, and LAA confers no real clinical benefit but significantly exacerbates hemorrhagic morbidity. Consequently, OAC monotherapy should remain the standard of care, while combined therapy should be avoided in routine practice.
- 25 August 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (9) , 735
Combined antithrombotic therapy vs. oral anticoagulation alone for ischemic stroke with concomitant atrial fibrillation and large artery atherosclerosis: a systematic review and meta-analysis
Background Treating ischemic stroke patients who have both nonvalvular atrial fibrillation (NVAF) and large artery atherosclerosis (LAA) presents a clinical challenge. It remains unclear whether adding antiplatelet therapy (APT) to oral anticoagulation (OAC) reduces stroke risk or only increases the danger of hemorrhage. Methods We conducted a systematic review and meta-analysis of randomized and observational studies to compare OAC monotherapy against combined therapy (OAC + APT) in patients with recent ischemic stroke, NVAF, and LAA. PubMed, Embase, Scopus, Cochrane Library, and Web of Science were searched from inception to December 2025. We applied random-effects models to estimate Risk Ratios (RR). Results Seven studies comprising 14,884 patients were included. Combined therapy was not associated with a significant reduction in recurrent ischemic stroke (RR 0.98; 95% CI: 0.92–1.04; p = 0.55) or all-cause mortality (RR 1.11; 95% CI: 0.98–1.26; p = 0.09) compared to OAC monotherapy. Conversely, the combined strategy was associated with a statistically significant increase in the risk of major bleeding (RR 1.49; 95% CI: 1.04–2.15; p = 0.03). Conclusion Our findings indicate that adding antiplatelets to anticoagulation in patients with stroke, AF, and LAA confers no real clinical benefit but significantly exacerbates hemorrhagic morbidity. Consequently, OAC monotherapy should remain the standard of care, while combined therapy should be avoided in routine practice.
- Open Access
- 22 July 2026
- Published by Elsevier in Neurochirurgie
- Vol. 72 (5) , 101854
Effectiveness of anti-siphon devices in CSF shunts for preventing overdrainage in normal pressure hydrocephalus: a systematic review and meta-analysis
- 22 July 2026
- Published by Elsevier in Neurochirurgie
- Vol. 72 (5) , 101854
Open AccessEffectiveness of anti-siphon devices in CSF shunts for preventing overdrainage in normal pressure hydrocephalus: a systematic review and meta-analysis
- Open Access
- 30 March 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (7) , 2051-2052
Correction: Intracardiac versus transesophageal echocardiography in atrial fibrillation ablation: a systematic review and meta-analysis
- 30 March 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (7) , 2051-2052
Open AccessCorrection: Intracardiac versus transesophageal echocardiography in atrial fibrillation ablation: a systematic review and meta-analysis
- 27 March 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 49 (6) , 742-752
Radiofrequency Needle and Conventional Mechanical Needle for Transseptal Access: A Systematic Review and Meta‐Analysis
Background: Transseptal puncture (TSP) is essential for various structural and electrophysiological cardiac procedures. However, the conventional mechanical needle can be challenging in complex anatomies. Radiofrequency (RF)‐assisted puncture systems offer an alternative to facilitate septal crossing and potentially reduce complications. This study aimed to evaluate the efficacy and safety of RF needle TSP compared with the conventional mechanical approach. Materials and Methods: A systematic review and meta‐analysis was conducted following PRISMA guidelines (PROSPERO: CRD420251272470). Primary efficacy outcomes included unassisted success, crossover, and TSP and fluoroscopy time, failure to obtain left atrial access, while safety outcomes included pericardial effusion or cardiac tamponade. Statistical analyses were conducted in R software (version 4.5.1) risk ratios (RR) and differences (MD), and heterogeneity was assessed by I 2 statistics. Results: This review included nine studies, amongst them randomized and nonrandomized. The RF needle demonstrated statistically significant superiority in several efficacy outcomes: increased unassisted success (RR: 1.05; 95% CI: 1.01–1.10), marked reduction risk in crossover rate (RR: 0.11; 95% CI: 0.03–0.38), and failure to obtain transseptal access (RR: 0.11; 95% CI: 0.04–0.33). Furthermore, the RF technique significantly reduced TSP time (MD: −154.7 s) and fluoroscopy time (MD: –84.5 s). Successful TSP rates (RR: 1.03; 95% CI: 0.99–1.06) and pericardial effusion or cardiac tamponade (RR: 0.55; 95% CI: 0.12–2.57) were comparable between groups. Conclusion: RF‐assisted TSP demonstrated superior performance compared with the conventional mechanical technique, offering higher unassisted primary efficacy, reducing access failures, and improving procedural efficiency. Although major complication rates are similar, RF may be considered a preferred strategy, especially in complex anatomies, due to its predictability and potential benefit in neurological safety.
- 27 March 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 49 (6) , 742-752
Radiofrequency Needle and Conventional Mechanical Needle for Transseptal Access: A Systematic Review and Meta‐Analysis
Background: Transseptal puncture (TSP) is essential for various structural and electrophysiological cardiac procedures. However, the conventional mechanical needle can be challenging in complex anatomies. Radiofrequency (RF)‐assisted puncture systems offer an alternative to facilitate septal crossing and potentially reduce complications. This study aimed to evaluate the efficacy and safety of RF needle TSP compared with the conventional mechanical approach. Materials and Methods: A systematic review and meta‐analysis was conducted following PRISMA guidelines (PROSPERO: CRD420251272470). Primary efficacy outcomes included unassisted success, crossover, and TSP and fluoroscopy time, failure to obtain left atrial access, while safety outcomes included pericardial effusion or cardiac tamponade. Statistical analyses were conducted in R software (version 4.5.1) risk ratios (RR) and differences (MD), and heterogeneity was assessed by I 2 statistics. Results: This review included nine studies, amongst them randomized and nonrandomized. The RF needle demonstrated statistically significant superiority in several efficacy outcomes: increased unassisted success (RR: 1.05; 95% CI: 1.01–1.10), marked reduction risk in crossover rate (RR: 0.11; 95% CI: 0.03–0.38), and failure to obtain transseptal access (RR: 0.11; 95% CI: 0.04–0.33). Furthermore, the RF technique significantly reduced TSP time (MD: −154.7 s) and fluoroscopy time (MD: –84.5 s). Successful TSP rates (RR: 1.03; 95% CI: 0.99–1.06) and pericardial effusion or cardiac tamponade (RR: 0.55; 95% CI: 0.12–2.57) were comparable between groups. Conclusion: RF‐assisted TSP demonstrated superior performance compared with the conventional mechanical technique, offering higher unassisted primary efficacy, reducing access failures, and improving procedural efficiency. Although major complication rates are similar, RF may be considered a preferred strategy, especially in complex anatomies, due to its predictability and potential benefit in neurological safety.
- 18 March 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (7) , 2041-2050
Intracardiac versus transesophageal echocardiography in atrial fibrillation ablation: a systematic review and meta-analysis
- 18 March 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (7) , 2041-2050
Intracardiac versus transesophageal echocardiography in atrial fibrillation ablation: a systematic review and meta-analysis
- 13 February 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (1) , 47
Breathe poorly, recover worse? The impact of obstructive sleep apnea on cardiac surgery outcomes – an updated systematic review and meta-analysis
- 13 February 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (1) , 47
Breathe poorly, recover worse? The impact of obstructive sleep apnea on cardiac surgery outcomes – an updated systematic review and meta-analysis
- Open Access
- 15 June 2024
- Published by Headache Medicine in Headache Medicine
- Vol. 15 (2) , 86-91
INOVAÇÃO MÉDICA NA AMAZÔNIA: O PRIMEIRO AMBULATÓRIO UNIVERSITÁRIO DE CEFALEIAS
Introdução: As cefaleias são uma das principais queixas neurológicas em todo o mundo. No Brasil, a falta de centros especializados, especialmente em regiões menos desenvolvidas, dificulta o tratamento adequado, com impactos na saúde e na qualidade de vida dessas populações. Objetivo: Relatar a implementação do primeiro ambulatório universitário de cefaleias da Amazônia brasileira. Métodos: relato de experiência que visa identificar, registrar e analisar características, fatores ou variáveis relacionadas à implementação de um ambulatório de cefaleias na Amazônia brasileira. Resultados: O Ambulatório de Cefaleias da Amazônia, pioneiro na região, atendeu 70 pacientes entre maio de 2023 e fevereiro de 2024. Cinquenta e oito pacientes estão em acompanhamento contínuo, enquanto 36 aguardam primeira consulta. Dados preliminares demonstram a presença maior do sexo feminino, com média de idade de 37,96 anos, público estudantil e diagnóstico de migrânea episódica sem aura. Os atendimentos, presenciais e por telemedicina, priorizam pacientes financeiramente desfavorecidos, promovendo acessibilidade ao tratamento especializado em cefaleia. O serviço, oferecido presencialmente na cidade de Santarém e por telemedicina a comunidades ribeirinhas, representa um avanço no manejo das cefaleias na região, melhorando significativamente a qualidade de vida dos pacientes. Estudantes de medicina e médicos residentes acompanham os especialistas, contribuindo para sua formação prática em saúde. Conclusão: A inauguração do primeiro laboratório de cefaleias na Amazônia é um marco importante na saúde e pesquisa médica regional. Além de preencher uma lacuna no tratamento dessas condições, promove a capacitação de profissionais locais, melhorando a qualidade de vida dos pacientes e impulsionando avanços na saúde. Palavras-chave: assistência ambulatorial, cefaleia, Amazônia.
- 15 June 2024
- Published by Headache Medicine in Headache Medicine
- Vol. 15 (2) , 86-91
Open AccessINOVAÇÃO MÉDICA NA AMAZÔNIA: O PRIMEIRO AMBULATÓRIO UNIVERSITÁRIO DE CEFALEIAS
Introdução: As cefaleias são uma das principais queixas neurológicas em todo o mundo. No Brasil, a falta de centros especializados, especialmente em regiões menos desenvolvidas, dificulta o tratamento adequado, com impactos na saúde e na qualidade de vida dessas populações. Objetivo: Relatar a implementação do primeiro ambulatório universitário de cefaleias da Amazônia brasileira. Métodos: relato de experiência que visa identificar, registrar e analisar características, fatores ou variáveis relacionadas à implementação de um ambulatório de cefaleias na Amazônia brasileira. Resultados: O Ambulatório de Cefaleias da Amazônia, pioneiro na região, atendeu 70 pacientes entre maio de 2023 e fevereiro de 2024. Cinquenta e oito pacientes estão em acompanhamento contínuo, enquanto 36 aguardam primeira consulta. Dados preliminares demonstram a presença maior do sexo feminino, com média de idade de 37,96 anos, público estudantil e diagnóstico de migrânea episódica sem aura. Os atendimentos, presenciais e por telemedicina, priorizam pacientes financeiramente desfavorecidos, promovendo acessibilidade ao tratamento especializado em cefaleia. O serviço, oferecido presencialmente na cidade de Santarém e por telemedicina a comunidades ribeirinhas, representa um avanço no manejo das cefaleias na região, melhorando significativamente a qualidade de vida dos pacientes. Estudantes de medicina e médicos residentes acompanham os especialistas, contribuindo para sua formação prática em saúde. Conclusão: A inauguração do primeiro laboratório de cefaleias na Amazônia é um marco importante na saúde e pesquisa médica regional. Além de preencher uma lacuna no tratamento dessas condições, promove a capacitação de profissionais locais, melhorando a qualidade de vida dos pacientes e impulsionando avanços na saúde. Palavras-chave: assistência ambulatorial, cefaleia, Amazônia.